Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India

Background: The evidence from various studies showed that patients with sickle cell disease (SCD) have altered components of hemostasis such as platelet function, procoagulant, anticoagulant and fibrinolytic pathways, and modulate inflammation such as acute or chronic inflammatory state. These compo...

Full description

Bibliographic Details
Main Authors: Gajendra Kumar Gupta, Purnima Dey Sarkar, Rohit Manyal, Mithun Singh Rajput
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Biomedical and Biotechnology Research Journal
Subjects:
Online Access:http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=81;epage=85;aulast=Gupta
_version_ 1811239244661784576
author Gajendra Kumar Gupta
Purnima Dey Sarkar
Rohit Manyal
Mithun Singh Rajput
author_facet Gajendra Kumar Gupta
Purnima Dey Sarkar
Rohit Manyal
Mithun Singh Rajput
author_sort Gajendra Kumar Gupta
collection DOAJ
description Background: The evidence from various studies showed that patients with sickle cell disease (SCD) have altered components of hemostasis such as platelet function, procoagulant, anticoagulant and fibrinolytic pathways, and modulate inflammation such as acute or chronic inflammatory state. These components may alter based on race, regions, or environment. Assessment of the hemostatic parameters in our region is imperative because the altered components so involved may give an insight as to the clinical phenotypes of Arab-Indian haplotypes we have in our setting. The objective of present study is to assess basic hemostatic and inflammatory parameters in patients with SCD during steady state at a tertiary care hospital. Methods: Blood samples of 95 patients with SCD during steady state attending M. Y. Hospital, Indore, India, during the period of November 2019 to March 2020 were screened for C-reactive protein (CRP) levels and platelet counts using latex enhanced immune-turbidimetric assay and hemotology analyzer, respectively, while prothrombin time (PT) and activated partial thromboplastin time (APTT) by automated coagulation analyzer. Results: It was observed that there is no significant difference among the mean platelet count (321.9 ± 97.63 × 109/l) of SCD patients and control groups (P = 0.69). CRP levels (6.60 ± 2.83 mg/l) were found to be significantly increased (P < 0.01) in SCD patients in comparison with their respective control. The mean PT (15.21 ± 1.58 s) and APTT values (37.69 ± 2.50 s) were found to be significantly increased (P < 0.05 for both) in SCD patient group when compared with control group. Conclusion: The study confirms that patients with SCD in steady state have significant prolonged coagulation indices. These can be an evidence of hypercoagulable state in SCD and may provide reference values appropriate for therapeutic target. We recommend that patients of SCD especially those with severe vaso-occlusive crises should have these hemostatic parameters as a basic test and during routine clinic follow-up for improved management.
first_indexed 2024-04-12T12:57:29Z
format Article
id doaj.art-f9128f730caa4f41b449eb59de8acc92
institution Directory Open Access Journal
issn 2588-9834
2588-9842
language English
last_indexed 2024-04-12T12:57:29Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Biomedical and Biotechnology Research Journal
spelling doaj.art-f9128f730caa4f41b449eb59de8acc922022-12-22T03:32:18ZengWolters Kluwer Medknow PublicationsBiomedical and Biotechnology Research Journal2588-98342588-98422022-01-0161818510.4103/bbrj.bbrj_162_21Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, IndiaGajendra Kumar GuptaPurnima Dey SarkarRohit ManyalMithun Singh RajputBackground: The evidence from various studies showed that patients with sickle cell disease (SCD) have altered components of hemostasis such as platelet function, procoagulant, anticoagulant and fibrinolytic pathways, and modulate inflammation such as acute or chronic inflammatory state. These components may alter based on race, regions, or environment. Assessment of the hemostatic parameters in our region is imperative because the altered components so involved may give an insight as to the clinical phenotypes of Arab-Indian haplotypes we have in our setting. The objective of present study is to assess basic hemostatic and inflammatory parameters in patients with SCD during steady state at a tertiary care hospital. Methods: Blood samples of 95 patients with SCD during steady state attending M. Y. Hospital, Indore, India, during the period of November 2019 to March 2020 were screened for C-reactive protein (CRP) levels and platelet counts using latex enhanced immune-turbidimetric assay and hemotology analyzer, respectively, while prothrombin time (PT) and activated partial thromboplastin time (APTT) by automated coagulation analyzer. Results: It was observed that there is no significant difference among the mean platelet count (321.9 ± 97.63 × 109/l) of SCD patients and control groups (P = 0.69). CRP levels (6.60 ± 2.83 mg/l) were found to be significantly increased (P < 0.01) in SCD patients in comparison with their respective control. The mean PT (15.21 ± 1.58 s) and APTT values (37.69 ± 2.50 s) were found to be significantly increased (P < 0.05 for both) in SCD patient group when compared with control group. Conclusion: The study confirms that patients with SCD in steady state have significant prolonged coagulation indices. These can be an evidence of hypercoagulable state in SCD and may provide reference values appropriate for therapeutic target. We recommend that patients of SCD especially those with severe vaso-occlusive crises should have these hemostatic parameters as a basic test and during routine clinic follow-up for improved management.http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=81;epage=85;aulast=Guptaactivated partial thromboplastin timec-reactive proteinplateletprothrombin timesickle cell disease
spellingShingle Gajendra Kumar Gupta
Purnima Dey Sarkar
Rohit Manyal
Mithun Singh Rajput
Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
Biomedical and Biotechnology Research Journal
activated partial thromboplastin time
c-reactive protein
platelet
prothrombin time
sickle cell disease
title Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
title_full Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
title_fullStr Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
title_full_unstemmed Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
title_short Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
title_sort sickle cell disease assessment of hemostasis parameters in steady state patients at tertiary care hospital indore india
topic activated partial thromboplastin time
c-reactive protein
platelet
prothrombin time
sickle cell disease
url http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=81;epage=85;aulast=Gupta
work_keys_str_mv AT gajendrakumargupta sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia
AT purnimadeysarkar sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia
AT rohitmanyal sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia
AT mithunsinghrajput sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia